Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre, Open-label Randomised Trial to Assess the Efficacy, Safety and Tolerability of Triple Artemisinin-based Combination Therapies (TACTs) Com-pared to Artemisinin-based Combination Therapies (ACTs) in Uncomplicated Falciparum Malaria and to Map the Geographical Spread of Artemisinin and Partner Drug Resistance

NCT02453308 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT02453308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02453308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre, Open-label Randomised Trial to Assess the Efficacy, Safety and Tolerability of Triple Artemisinin-based Combination Therapies (TACTs) Com-pared to Artemisinin-based Combination Therapies (ACTs) in Uncomplicated Falciparum Malaria and to Map the Geographical Spread of Artemisinin and Partner Drug Resistance
Lead sponsor
University of Oxford
Phase
Phase 2/3
Overall status
Completed
Start date
August 31, 2015
Completion date
March 31, 2018
Enrollment
1,110 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

malaria, falciparum